About Spear Bio
Spear Bio is a company based in Boston (United States) founded in 2021 by Feng Xuan and Peng Yin. Spear Bio has raised $48.96 million across 4 funding rounds from investors including Bio-Techne, Foresite Capital and Maverick Ventures. Spear Bio offers products and services including SPEAR Technology and Workflow & Automation. Spear Bio operates in a competitive market with competitors including Abingdon Health, Olink, US BioTek Laboratories, Eclipse Bio and Virtue Diagnostics, among others.
- Headquarter Boston, United States
- Founders Feng Xuan, Peng Yin
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spear Bio Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$48.96 M (USD)
in 4 rounds
-
Latest Funding Round
$45 M (USD), Series A
Jul 23, 2024
-
Investors
Bio-Techne
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spear Bio
Spear Bio offers a comprehensive portfolio of products and services, including SPEAR Technology and Workflow & Automation.
Enables ultra-sensitive biomarker detection from minimal samples with high accuracy.
Automates immunoassay processes for efficient research and development tasks.
People of Spear Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Spear Bio
Spear Bio has successfully raised a total of $48.96M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $45 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Spear Bio
Spear Bio has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Bio-Techne, Foresite Capital and Maverick Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Locked | Locked | Locked | |
|
Early-stage tech and life-sciences firms are funded across the US.
|
Locked | Locked | Locked | |
|
Venture capital firm backed by Yongjin Group
|
Locked | Locked | Locked |
Investor details for Spear Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spear Bio
Investment portfolio details for Spear Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spear Bio
Detailed financials for Spear Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spear Bio Comparisons
Peer comparison for Spear Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spear Bio
Spear Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Olink, US BioTek Laboratories, Eclipse Bio and Virtue Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of immunoassays for diagnostic purposes
|
|
| Locked | Locked | Locked |
Provider of products and services for human protein biomarker research and development
|
|
| Locked | Locked | Locked |
Provider of enzyme-linked immunosorbent assay technology services
|
|
| Locked | Locked | Locked |
Cell-free immunoassays are developed to identify RNA binding protein targets.
|
|
| Locked | Locked | Locked |
An in vitro assay platform is provided for diagnostic solutions.
|
Detailed competitors of Spear Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spear Bio
Complete news archive for Spear Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spear Bio
Spear Bio was founded in 2021.
Spear Bio is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Spear Bio is a funded company, having raised a total of $48.96M across 4 funding rounds to date.
Spear Bio was founded in 2021 in Boston, United States, within the biotechnology sector focused on diagnostics and research tools. Ultrasensitive immunoassays and proteomics platforms are developed by the company to detect protein biomarkers. TNAB-sure SARS-CoV-2 neutralizing antibody test kits are offered for antibody detection in small samples. A reagent-based platform is provided for ultrasensitive protein detection in low-volume samples, supporting applications in research and clinical diagnostics.
Spear Bio's top competitors include Abingdon Health, Eclipse Bio and Olink.
Spear Bio offers SPEAR Technology and Workflow & Automation.
Spear Bio has 7 investors. Key investors include Bio-Techne, Foresite Capital, Maverick Ventures, Yonjin Capital, and CDH.